Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...
Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects approximately 112 per 100,000 adults worldwide. It ...
The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...
Bristol-Myers Squibb (BMY) stock in focus as psoriasis drug Sotyktu shows promising results in treating psoriatic arthritis ...
Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...
Rebecca Haberman, MD, of NYU Langone Health, highlights precision medicine and potential prevention strategies, two areas of promising psoriatic arthritis research.
Arthritis is one of the most common chronic conditions affecting millions of people worldwide. Yet, many fail to recognize ...
MoveAbility, from the Black Mountain Center for the Arts, redefines dance education by utilizing adaptive movement and ...
The following is a summary of “Potentially Avoidable Emergency Department Utilization by Persons With Psoriatic Arthritis and ...
Bristol Myers Squibb's Phase 3 POETYK PsA-2 trial shows Sotyktu improved psoriatic arthritis symptoms, meeting primary and ...
HealthDay on MSN5d
Overactive Bladder Positively Associated With ArthritisPositive association seen between osteoarthritis and OAB, but not for rheumatoid arthritis or psoriatic arthritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results